A handful of large capitalization healthcare stocks have weathered the turbulent market very well this year. Overall, the healthcare sector is outperforming the broader market, providing greater potential for relative safety and superior gains. The Health Care SPDR (NYSE:XLV) ETF is up 5.14% year to date, compared to the S&P 500 SPDR (NYSE:SPY), which is still down 2.24%. Therefore, the healthcare sector has been one of the market leaders to the upside, and there are four stocks in the sector that have been performing especially well.

Abbott Labs (NYSE:ABT) is up 13.49% this year to $54.27, from $47.82. The stock has outperformed and continues to show strength. From August until now, the stock has risen steadily and created a higher low in October, while the broader market made a new low. The stock is consolidating under $55 for almost two months after hitting a 52-week high of $55.62 on October 19. A breakout above $55 is a strong signal, with a move above $55.61 confirming the uptrend is continuing. The initial upside target is $58.50 followed by $60. There is resistance at $56.50, so this area should be watched to see how the stock reacts. Primary support is at $52, and a drop below that level indicates at least short-term weakness.

Bristol-Meyers Squibb (NYSE:BMY) is having a good year so far, up 24.83% to $33.18, from $26.58. The stock has been in an uptrend all year, and recently made a new 52-week high at $33.72. The stock is pushing into overbought territory based on the RSI and may see a pullback, which should provide a buying opportunity between the 50-day moving average and $30. $30 is the primary support level, therefore a drop below is a warning signal. The current price level has not been seen since 2002, therefore there is little resistance overhead and $37 to $37.50 is the initial target.

Humana (NYSE:HUM) has been on fire, up 57.06% this year to $86.54 from $55.01. Despite being up so much already, the stock is still exhibiting strength, recently putting in a new 52-week high at $90.76. The stock been ranging over the last week between $87.50 and $85. This is a potential buying opportunity, with a stop below $85, or below $80 for longer-term traders. The November low is at $80.89 - a drop below is a warning signal. If the stock continues to make new highs, the next target is the psychologically important $100. One cause for concern is a diverging RSI indicator, it is not confirming the price moves higher. It does not mean the stock can't go higher (a divergence can last a long time) but it is something to be aware of. (For more, see An Introduction To The RSI.)

Alexion Pharmaceuticals (Nasdaq:ALXN) exploded higher in June and again in August and has not looked back since. It is up 60.11% year to date to $65.11 from $40.67. After a strong run up into October, the price has been moving sideways recently. The breakout of the range which is developing will ultimately tell if this stock still has room to the upside. A rise above $70.50 would break the range to the upside and could take the price to $80. On the other hand, there are two support levels on the downside: $62 and $59.42. If the stock breaks below $62 it is a warning signal, but a break below $59.42 is likely to bring in more aggressive selling. Like Humana, Alexion is also showing a divergence on the RSI. Price can still go higher, but it does indicate that a break to the downside is possible. (For more, see What does it mean to use technical divergence in trading?)

The Bottom Line
The healthcare sector has been doing well this year and certain stocks have provided great returns and are still showing potential. These stocks have been market leaders and are still showing price strength as the uptrends continue. That said, a break below the primary support levels mentioned are warning signals for a further correction. While there is an RSI divergence on two of the stocks, divergence is not a good timing indicator. Therefore, price is the ultimate indicator, and currently these stocks are strong until proven otherwise. (For more, see 3 Slow-And-Steady Healthcare Stocks)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Charts courtesy of stockcharts.com

At the time of writing, Cory Mitchell did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Chart Advisor

    How Are You Trading The Breakdown In Growth Stocks? (VOOG, IWF)

    Based on the charts of these two ETFs, bearish traders will start turning their attention to growth stocks.
  2. Mutual Funds & ETFs

    Pimco’s Top Funds for Retirement Income

    Once you're living off the money you've saved for retirement, is it invested in the right assets? Here are some from PIMCO that may be good options.
  3. Chart Advisor

    Watch This ETF For Signs Of A Reversal (BCX)

    Trying to determine if the commodity markets are ready for a bounce? Take a look at the analysis of this ETF to find out if now is the time to buy.
  4. Mutual Funds & ETFs

    ETFs Can Be Safe Investments, If Used Correctly

    Learn about how ETFs can be a safe investment option if you know which funds to choose, including the basics of both indexed and leveraged ETFs.
  5. Mutual Funds & ETFs

    The Top 5 Large Cap Core ETFs for 2016 (VUG, SPLV)

    Look out for these five ETFs in 2016, and learn why investors should closely watch how the Federal Reserve moves heading into the new year.
  6. Chart Advisor

    Breakout Opportunity Stocks: CPA, GNRC, WWE

    After a period of contracting volatility, watch for breakouts and bigger moves to come in these stocks.
  7. Economics

    India: Why it Might Pay to Be Bullish Right Now

    Many investors are bullish on India for all the right reasons. Does it present an investing opportunity?
  8. Investing Basics

    Building My Portfolio with BlackRock ETFs and Mutual Funds (ITOT, IXUS)

    Find out how to construct the ideal investment portfolio utilizing BlackRock's tools, resources and its popular low-cost exchange-traded funds (ETFs).
  9. Investing

    3 Things About International Investing and Currency

    As world monetary policy continues to diverge rocking bottom on interest rates while the Fed raises them, expect currencies to continue their bumpy ride.
  10. Chart Advisor

    These 3 ETFs Suggest Commodities Are Headed Lower (COMT,CCX,DBC)

    The charts of these three exchange traded funds suggest that commodities are stuck in a downtrend and it doesn't look like it will reverse any time soon.
RELATED FAQS
  1. What is Fibonacci retracement, and where do the ratios that are used come from?

    Fibonacci retracement is a very popular tool among technical traders and is based on the key numbers identified by mathematician ... Read Full Answer >>
  2. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  3. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  4. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  5. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  6. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center